SYMBIOTEC vs MAXHEALTH: Stock Comparison
Head-to-head financial and trading comparison between Symbiotec Pharmalab Limited (SYMBIOTEC) and Max Healthcare Institute Limited (MAXHEALTH) in the Cross-Sector Peers sector.
SYMBIOTEC
NSE: SYMBIOTECMAXHEALTH
NSE: MAXHEALTHKey Metrics Comparison Table
| Metric | SYMBIOTEC | MAXHEALTH | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹1,087.50 | ₹883.80 | — |
| 1-Year Price Return | -0.93% | -12.61% | SYMBIOTEC (11.68% higher) |
| 52-Week High | ₹1,198.00 | ₹1,153.40 | — |
| 52-Week Low | ₹1,003.35 | ₹873.40 | — |
| 30-Day Annualized Volatility | 53.35% | 31.96% | MAXHEALTH (Steadier) |
| 30-Day Average Daily Volume | 2,798,957 | 2,642,110 | SYMBIOTEC (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between SYMBIOTEC and MAXHEALTH, which stock gave better returns over the last year?
SYMBIOTEC has outperformed MAXHEALTH over the past 12 months with a gain of -0.93% compared to -12.61%.
Which stock is less volatile: SYMBIOTEC or MAXHEALTH?
MAXHEALTH demonstrated lower price volatility (31.96% annualized) compared to SYMBIOTEC (53.35%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of SYMBIOTEC vs MAXHEALTH?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are SYMBIOTEC and MAXHEALTH direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.